Published Online
on December 11, 2003

A more recent version of this article appeared on January 1, 2004

This Article Full Text (PDF) All Versions of this Article: 35/1/40    most recent 01.STR.0000106909.75418.E4v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lichy, C. Articles by Grau, A. Search for Related Content PubMed PubMed Citation Articles by Lichy, C. Articles by Grau, A. Related Collections Coagulation Genetics of Stroke

Submitted on September 18, 2003
Accepted on September 18, 2003

A Common Polymorphism of the Protein Z Gene Is Associated With Protein Z Plasma Levels and With Risk of Cerebral Ischemia in the Young

C. Lichy MD^*; S. Kropp PhD; T. Dong-Si MD; J. Genius MD; T. Dolan; T. Hampe; F. Stoll; K. Reuner MD; C. Grond-Ginsbach PhD; and A. Grau MD

From the Department of Neurology, University of Heidelberg (C.L., T.D-S., J.G., T.D., T.H., F.S., C.G-G., A.G.); Department of Epidemiology, Deutsches Krebsforschungszentrum Heidelberg (S.K.); and Institute for Medical Laboratory Diagnostics, Städtisches Klinikum Karlsruhe (K.R.), Karlsruhe, Germany.

^* To whom correspondence should be addressed. E-mail: christoph_lichy{at}med.uni-heidelberg.de.

Background and Purpose--The vitamin K-dependent protein Z (PZ) has been shown to possess anticoagulant as well as procoagulant properties. Plasma levels of PZ show a broad interindividual variation, but it is unknown to which extent this variation is under genetic control. Recent clinical studies revealed contradictory results on the association of PZ plasma levels and the risk of ischemic stroke.

Methods--We performed a case-control study including 200 patients with cerebral ischemia aged 50 years and 199 control subjects from the same South German region. We investigated a possible association of 2 common single nucleotide mutations in the PZ gene with the risk of cerebral ischemia. Furthermore, enzyme-linked immunosorbent assay measurements were done in control subjects without vascular disease to detect a potential association of different genotypes with PZ plasma (antigen) levels.

Results--In patients, the frequency of the A allele of the intron F polymorphism G79A was significantly lower than in controls (15.7% versus 24.4%; odds ratio, 0.58; 95% CI, 0.39 to 0.86; P=0.007; adjusted for age, sex, and conventional risk factors). The G allele of the promoter polymorphism A-13G tended to be less common in patients (4.2% versus 7.0%; adjusted odds ratio, 0.56; 95% CI, 0.28 to 1.13; P=0.105). In 42 control subjects, the A allele of the intron F polymorphism was associated with lower PZ antigen levels (P=0.0032; Spearman correlation coefficient r_s=-0.48).

Conclusions--The A allele of an intron F polymorphism of the PZ gene appears to be a novel protective genetic marker for the risk of cerebral ischemia in young adults. In the context of juvenile stroke, high PZ plasma levels may represent a prothrombotic condition.

Key words: cerebral ischemia • polymorphism • protein Z

This article has been cited by other articles:

				J. J. Martin, I. Hausser, P. Lyrer, O. Busse, R. Schwarz, R. Schneider, T. Brandt, M. Kloss, M. Schwaninger, S. Engelter, et al. Familial Cervical Artery Dissections: Clinical, Morphologic, and Genetic Studies Stroke, December 1, 2006; 37(12): 2924 - 2929. [Abstract] [Full Text] [PDF]

				M. J. Heeb, K. M. Cabral, and L. Ruan Down-regulation of Factor IXa in the Factor Xase Complex by Protein Z-dependent Protease Inhibitor J. Biol. Chem., October 7, 2005; 280(40): 33819 - 33825. [Abstract] [Full Text] [PDF]

				F. Sofi, F. Cesari, G. F. Gensini, R. Abbate, S. Fedi, J. W. Eikelboom, J. Staton, and G. J. Hankey Protein Z Levels, Protein Z G79A Polymorphism, and Prothrombotic Conditions * Response: Stroke, September 1, 2005; 36(9): 1821 - 1822. [Full Text] [PDF]

				G. Altarescu, D. F. Moore, and R. Schiffmann Effect of genetic modifiers on cerebral lesions in Fabry disease Neurology, June 28, 2005; 64(12): 2148 - 2150. [Abstract] [Full Text] [PDF]

				J. Staton, M. Sayer, G.J. Hankey, V. Cole, J. Thom, and J.W. Eikelboom Protein Z Gene Polymorphisms, Protein Z Concentrations, and Ischemic Stroke Stroke, June 1, 2005; 36(6): 1123 - 1127. [Abstract] [Full Text] [PDF]

				M. Souri, S. Koseki-Kuno, H. Iwata, B. Kemkes-Matthes, and A. Ichinose A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency Blood, April 15, 2005; 105(8): 3149 - 3154. [Abstract] [Full Text] [PDF]

				L. Anderson Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol., February 15, 2005; 563(1): 23 - 60. [Abstract] [Full Text] [PDF]